Filed: 2/13/2026ACC: 0001172661-26-000728
📋 What this filing means
MATRIX CAPITAL MANAGEMENT COMPANY, LP filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $57.62M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$57.62M
Total AUM (reported)
7.40M
Total Shares
Allocation by class
COM$57.62M100.0%
Portfolio Concentration
Top 3$57.62M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 7.40M
Sole
Full voting authority
7.40M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
AURA BIOSCIENCES INC
SOLEShares6.92M
TypeSH
Market value$37.73M
65.48%
Sole
6.92M
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares480K
TypeSH
Market value$19.89M
34.52%
Sole
480K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AURA BIOSCIENCES INCSOLE | COM | 6.92M | SH | $37.73M 65.48% | 6.92M | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 480K | SH | $19.89M 34.52% | 480K | 0.00 | 0.00 |